申请人:GLAXO GROUP LTD
公开号:WO2013160419A1
公开(公告)日:2013-10-31
The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ.
本发明涉及新型视黄醛相关孤儿受体γ(RORγ)调节剂,其制备方法,含有这些调节剂的药物组合物,以及它们在治疗由RORγ介导的炎症性、代谢性和自身免疫性疾病中的应用。